Nanjing Medlander Medical Technology Co. Ltd. A (688273) — Cash Flow Reinvestment Rate
Nanjing Medlander Medical Technology Co. Ltd. A (688273) has a Cash Flow Reinvestment Rate of 3.85x as of December 2024, reinvesting CN¥471.54 Million (capex CN¥129.71 Million plus investments CN¥-341.83 Million) from operating cash flow of CN¥122.51 Million. See 688273 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nanjing Medlander Medical Technology Co. Ltd. A Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Nanjing Medlander Medical Technology Co. Ltd. A across 5 annual periods. For the full cash flow conversion analysis, see Nanjing Medlander Medical Technology Co. operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)
Year-by-year capital reinvestment analysis for Nanjing Medlander Medical Technology Co. Ltd. A. See 688273 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.85x | CN¥471.54 Million | CN¥122.51 Million | CN¥129.71 Million | ▲ +131.6% |
| 2023 | 1.66x | CN¥227.50 Million | CN¥136.91 Million | CN¥75.15 Million | ▲ +49.7% |
| 2022 | 1.11x | CN¥140.57 Million | CN¥126.67 Million | CN¥54.26 Million | ▲ +607.4% |
| 2021 | 0.16x | CN¥23.31 Million | CN¥148.60 Million | CN¥14.58 Million | ▼ -59.2% |
| 2020 | 0.38x | CN¥50.41 Million | CN¥131.10 Million | CN¥25.91 Million | — |